Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Demeulemeester

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Expert Opinion on Therapeutic Patents|March 27, 2014
LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 - 2014)Jonas Demeulemeester, Patrick Chaltin, Arnaud Marchand, et al.
Nature Biotechnology|July 20, 2021
A pan-cancer landscape of somatic mutations in non-unique regions of the human genomeMaxime Tarabichi, Jonas Demeulemeester, Annelien Verfaillie, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Discovery of small molecule HIV-1 integrase dimerization inhibitorsCristina Tintori, Jonas Demeulemeester, Luigi Franchi, et al.
Acta Crystallographica. Section F, Structural Biology Communications|June 11, 2014
Structure of transportin SR2, a karyopherin involved in human disease, in complex with RanVicky G Tsirkone, Katrien G Beutels, Jonas Demeulemeester, et al.
AIDS (London, England)|December 6, 2012
Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressorsRik Schrijvers, Jonas Demeulemeester, Jan De Rijck, et al.
The Journal of Biological Chemistry|August 9, 2012
Identification of residues in the C-terminal domain of HIV-1 integrase that mediate binding to the transportin-SR2 proteinStephanie De Houwer, Jonas Demeulemeester, Wannes Thys, et al.
Plos One|October 3, 2012
A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replicationErik Serrao, Wannes Thys, Jonas Demeulemeester, et al.
The Journal of Biological Chemistry|July 27, 2014
The HIV-1 integrase mutant R263A/K264A is 2-fold defective for TRN-SR2 binding and viral nuclear importStéphanie De Houwer, Jonas Demeulemeester, Wannes Thys, et al.
Molecular Therapy. Nucleic Acids|July 30, 2014
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory ElementsSara El Ashkar, Jan De Rijck, Jonas Demeulemeester, et al.
ACS Nano|March 25, 2014
HIV virions as nanoscopic test tubes for probing oligomerization of the integrase enzymeDoortje Borrenberghs, Wannes Thys, Susana Rocha, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Expert Opinion on Therapeutic Patents|March 27, 2014
LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 - 2014)Jonas Demeulemeester, Patrick Chaltin, Arnaud Marchand, et al.
Nature Biotechnology|July 20, 2021
A pan-cancer landscape of somatic mutations in non-unique regions of the human genomeMaxime Tarabichi, Jonas Demeulemeester, Annelien Verfaillie, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Discovery of small molecule HIV-1 integrase dimerization inhibitorsCristina Tintori, Jonas Demeulemeester, Luigi Franchi, et al.
Acta Crystallographica. Section F, Structural Biology Communications|June 11, 2014
Structure of transportin SR2, a karyopherin involved in human disease, in complex with RanVicky G Tsirkone, Katrien G Beutels, Jonas Demeulemeester, et al.
AIDS (London, England)|December 6, 2012
Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressorsRik Schrijvers, Jonas Demeulemeester, Jan De Rijck, et al.
The Journal of Biological Chemistry|August 9, 2012
Identification of residues in the C-terminal domain of HIV-1 integrase that mediate binding to the transportin-SR2 proteinStephanie De Houwer, Jonas Demeulemeester, Wannes Thys, et al.
Plos One|October 3, 2012
A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replicationErik Serrao, Wannes Thys, Jonas Demeulemeester, et al.
The Journal of Biological Chemistry|July 27, 2014
The HIV-1 integrase mutant R263A/K264A is 2-fold defective for TRN-SR2 binding and viral nuclear importStéphanie De Houwer, Jonas Demeulemeester, Wannes Thys, et al.
Molecular Therapy. Nucleic Acids|July 30, 2014
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory ElementsSara El Ashkar, Jan De Rijck, Jonas Demeulemeester, et al.
ACS Nano|March 25, 2014
HIV virions as nanoscopic test tubes for probing oligomerization of the integrase enzymeDoortje Borrenberghs, Wannes Thys, Susana Rocha, et al.
Pageof 8